Finn Partners has appointed communications veteran, Mina Volovitch, Paris head and Senior Partner for its global health practice.
Finn Partners has named Mina Volovitch (pictured) head of its Paris office and Senior Partner for the agency’s global health practice. She will report to Chantal Bowman-Boyles, Managing Partner, leading Europe and Gil Bashe, Managing Partner, Global Health at the firm.
Having spent more than 20 years in health communications, she has worked with leading names in medicine and public health including bioMérieux, Bristol Myers-Squibb, Lilly, Novartis, Roche, Sanofi Pasteur, Transgene, and the French Cancer Society, among numerous others.
Volovitch began her career at Merck working in marketing, before being elevated to Director of Communications at MSD Paris. She later joined the Mérieux Institute, where she served in a similar capacity. In 1987, she created Mynecom, a specialist healthcare communications agency.
Her experience includes running national and global professional and patient communications programmes, handling pharmaceuticals and health product issues, and expertise across AIDS, biotech, cardiology, immunology, infectious disease, medical devices, oncology, and vaccines.
“Our European offices are adding more health work encompassing biotechnology, patient advocacy, and health technology. Mina’s role as Finn Partners Paris office head and senior member of the global health practice demonstrates how our agency values exceptional talent,” said Bowman-Boyles.
